Skip to: Content
Skip to: Site Navigation
Skip to: Search
SUNDAY, NOVEMBER 8, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: Pfizer

Pfizer stories: 33 news summaries

1 - 20 of 33 Stories | 1 2 Next >>

Switch to grid view »

(Newser) - Pfizer will shell out $2.3 billion—a record for a health care fraud settlement—over deceptive marketing of its drugs, the Los Angeles Times reports. Pfizer and one of its subsidiaries marketed four drugs based on off-label uses specifically prohibited by the FDA. The settlement with the Justice... More »

MORE ABOUT:
Department of Justice • fraud • Health and Human Services • marketing • drug companies • Pfizer • civil lawsuits • Lyrica • fines • criminal prosecution • Bextra

 Drug Giants Target Cancer 

Scientific advances, potentially huge profits attract Big Pharma to cancer fight

Sep 2, 09 2:16 AM CDT
(Newser) - Major drug companies are tying their fortunes to cancer like never before, the New York Times reports. The firms—inspired by advancements in science as well as the high prices cancer drugs command—are pouring unprecedented resources into the search for new cancer drugs. The drug giants hope cancer treatments... More »

MORE ABOUT:
cancer • pharmaceutical companies • drug companies • Pfizer • cancer research • prescription drugs • pharmaceutical industry • cancer drug

MARKETS

 Tech Snaps Nadaq's Streak; 
 Dow Climbs 24 

Amazon, Microsoft fall after weak earnings

Jul 24, 09 3:24 PM CDT
(Newser) - The tech sector exerted downward pressure on stocks today, snapping the Nasdaq’s 12-day winning streak, the Wall Street Journal reports. Microsoft sank 8.9% after reporting a 29% drop in quarterly earnings, while Amazon fell 8.3% after also reporting a disappointing quarter. Alcoa, Pfizer, and Merck helped the... More »

MORE ABOUT:
Microsoft • Merck • Dow Jones • Alcoa • Pfizer • earnings reports • Nasdaq • quarterly reports • S&P 500 • Amazon

MARKETS

 Stocks Tread Water; Dow Up 5 

Goldman Sachs rises, Pfizer falls

Jul 9, 09 3:12 PM CDT
(Newser) - The stock market indices swung back and forth across a narrow range today as financials enjoyed advances but the health care sector declined, the Wall Street Journal reports. Goldman Sachs was up 3.69% after Bank of American Merrill Lynch upgraded Goldman shares from “neutral” to “buy.”... More »

MORE ABOUT:
health care • Bank of America • Goldman Sachs • Dow Jones • Pfizer • Merrill Lynch • Nasdaq • financial sector • S&P 500

Anti-Smoking Chantix, Zyban Pose Suicide Risk: FDA

Smokers with mental illnesses should avoid them, agency says

Jul 1, 09 4:59 PM CDT
(Newser) - The Food and Drug Administration is warning smokers about serious mental-illness risks of two smoking-cessation drugs, as reported suicides among their users increase. Chantix and Zyban must now carry the agency’s strongest warning label, the New York Times reports. The FDA isn’t trying to scare patients, an official... More »

MORE ABOUT:
FDA • pharmaceutical companies • GlaxoSmithKline • Pfizer • smoking cessation • Chantix • women's issues • Zyban

MARKETS

 Oil, Banks Steal 63 From Dow 


May 15, 09 3:13 PM CDT
(Newser) - Markets were off today on falling oil prices and a poor showing from the financial industry, the Wall Street Journal reports. The S&P energy index fell 2.4% and Bank of America, Pfizer, and Wal-Mart also saw declines. General Motors, whose low share price no longer significantly affects markets,... More »

MORE ABOUT:
stock market • NASDAQ • Bank of America • New York Stock Exchange • Dow Jones • General Motors • Pfizer • financial sector • S&P 500 • Wal-Mart • oil prices

Pfizer Offers Free Lipitor, Viagra to Jobless

70 drugs available to those who lost jobs since Jan. 1

May 14, 09 10:27 AM CDT
(AP) - Pfizer is unveiling a new program that will let people who have lost their jobs and health insurance keep taking some of its medications—including Lipitor and Viagra—for free for up to a year. The world’s biggest drugmaker will provide more than 70 of its prescription drugs free... More »

MORE ABOUT:
health care • health insurance • Pfizer • Viagra • unemployment • Lipitor • pharmaceutical industry • jobless • Jay-ZTV

MARKETS

 Drugs, Oil Push Dow Up 50 


May 12, 09 3:15 PM CDT
(Newser) - Financials dipped today as firms continued stock sell-offs to finance TARP repayments, but strong performance by drug and energy companies stabilized the market, the Wall Street Journal reports. Merck and Pfizer were up as much as 2% and 6%, respectively; oil got a boost from $60 barrels. The Dow was... More »

MORE ABOUT:
NASDAQ • Merck • New York Stock Exchange • Dow Jones • General Motors • Pfizer • financial markets • S&P 500 • oil prices • Jay-ZTV

ANALYSIS

Pfizer Deal's $22.5B in Loans Hasn't Unlocked Credit

$22.5B loan in deal to acquire Wyeth comes at 7-9% interest, and lenders can walk

Jan 27, 09 9:11 AM CST
(Newser) - Think Pfizer’s $68 billion deal to buy Wyeth, financed in part with $22.5 billion in loans, means credit markets have thawed? Think again, the Wall Street Journal reports. Pfizer’s lenders—including JPMorgan, Bank of America, Goldman, and Citigroup—are charging high interest (7%-9%, with loans due in... More »

MORE ABOUT:
Citigroup • Bank of America • Goldman Sachs • pharmaceutical companies • Pfizer • credit market • Wyeth • JPMorgan Chase • credit rating

MARKETS

 Dow Ticks Up 38 Amid Layoffs 

Home sales report boosts stocks

Jan 26, 09 3:16 PM CST
(Newser) - Stocks closed with mild gains today even as US firms announced roughly 50,000 job cuts, the Wall Street Journal reports. The market was buoyed by a report that home sales are picking up as buyers take advantage of low prices. The Dow closed up 38.47 at 8,116.... More »

MORE ABOUT:
Dow Jones • Pfizer • home sales • Nasdaq • Home Depot • Sprint • S&P 500

MARKET open

 Stocks Shrug Off Job Losses 

Pfizer deal drives gains

Jan 26, 09 8:58 AM CST
(Newser) - Pfizer’s massive deal to buy Wyeth helped investors shrug off the bloodbath at Caterpillar, Home Depot and Sprint-Nextel this morning, sending indexes slightly higher at the open. The Dow rose 55 points, while the S&P and Nasdaq rose 11 and 18 points respectively. Caterpillar fell 10% pre-market after... More »

MORE ABOUT:
stock market • McDonald's • Pfizer • earnings reports • Nasdaq • Caterpillar • Dow • Wyeth • S&P 500

 Pfizer Snaps Up Wyeth for $68B 

Merger would be largest pharma deal since GlaxoWellcome-SmithKline 2000 merger

Jan 26, 09 6:11 AM CST
(Newser) - The world’s largest drugmaker, Pfizer, is poised to become even more gargantuan after it agreed early this morning to buy rival Wyeth for $68 billion, reports the Wall Street Journal. In the first major merger to hit Wall Street in months, Pfizer will borrow $22.5 billion from... More »

MORE ABOUT:
Citigroup • Bank of America • Goldman Sachs • pharmaceutical companies • mergers and acquisitions • merger • Pfizer • credit • Wyeth • pharmaceutical industry • JPMorgan Chase • financial crisis

 Pfizer in Talks to Buy Wyeth  




Sources say drug maker plans $60B acquisition of rival Wyeth

Jan 23, 09 5:49 AM CST
(Newser) - Pfizer is seeking to create a Big Pharma behemoth with the acquisition of rival Wyeth, insiders tell the Wall Street Journal. The deal, expected to be worth around $60 billion, would make Pfizer—already the world's biggest drug company—big enough to redraw the map of the industry, although sources... More »

MORE ABOUT:
pharmaceutical companies • drug companies • mergers and acquisitions • merger • Pfizer • Wyeth • research and development • pharmaceutical industry

 Pfizer to Can 800 Researchers 

Company must cut R&D spending ahead of Lipitor patent expiration

Jan 13, 09 12:19 PM CST
(Newser) - Pfizer will eliminate the jobs of up to 800 researchers in 2009, starting today, the Wall Street Journal reports. The pharmaceutical giant is attempting to cut costs ahead of a $30 billion reduction in revenue expected in 2011 when its patent on the popular cholesterol drug Lipitor expires. But the... More »

MORE ABOUT:
layoffs • pharmaceutical companies • drug companies • Pfizer • research • generic drugs • Lipitor • pharmaceutical industry

ANALYSIS

Big Pharma Seeks Big Profits in Developing Nations

Drug Makers See Future in New Markets

Nov 15, 08 2:47 AM CST
(Newser) - The pharmaceutical industry is turning away from the US shores that helped fill its pockets and toward the developing world, the Economist reports. Massive growth has made markets like India and China too attractive to ignore, despite lower income levels and weaker patent laws. And many companies fear Barack Obama's... More »

MORE ABOUT:
China • India • pharmaceutical companies • Medicare • GlaxoSmithKline • Pfizer • emerging markets • pharmaceutical industry

FDA May Strengthen Chantix Label

Anti-smoking drug linked to more seizures, accidents

Oct 22, 08 5:25 PM CDT
(Newser) - The FDA may beef up its warning for the anti-smoking drug Chantix after an increase in the number of serious incidents linked to the drug, the Wall Street Journal reports. A drug-safety group tallied 1,001 reports of patients suffering seizures, blackouts, and loss of motor control—some while driving—... More »

MORE ABOUT:
FDA • drug companies • Pfizer • smoking cessation • side effects • Chantix

MARKETS

 Mixed News Keeps Gains Slim 

Markets absorb gloomy Fed data and continued oil drop

Jul 23, 08 3:15 PM CDT
(Newser) - The markets pared earlier gains to end just slightly positive today, amid mixed earnings reports and a gloomy-but-expected Federal Reserve data on the US economy, the Wall Street Journal reports. The Dow gained 29.88, closing at 11,632.38. The Nasdaq gained 21.92, settling at 2,325.88,... More »

MORE ABOUT:
Federal Reserve • Dow Jones • Pfizer • Nasdaq • Freddie Mac • Fannie Mae • S&P 500 • AT&T • Beige Book

Deal Delays Generic Lipitor Until 2011

Pact with Indian drug maker stands to net billions for Pfizer

Jun 18, 08 5:11 PM CDT
(Newser) - Pfizer has struck a deal with an Indian generic drug maker to delay a cheaper version of Lipitor in the US until November 2011. The agreement limiting generic versions of the cholesterol-lowering drug will translate into billions more in profits for Pfizer, the New York Times reports. Lipitor, the world's... More »

MORE ABOUT:
pharmaceutical companies • Pfizer • cholesterol lowering drug • Lipitor • pharmaceutical industry

Quit-Smoking Drug Linked to Heart Trouble, Dizziness

FAA bans pilots and air controllers from using Chantix after report

May 22, 08 7:39 AM CDT
(Newser) - Pfizer smoking-cessation drug Chantix has been linked to nearly a thousand serious incidents in the last quarter of 2007, the Wall Street Journal reports. A report from a drug safety group found that some users of the drug—already linked to depression and suicide—suffered heart trouble, diabetes, or accidents... More »

MORE ABOUT:
FDA • drug safety • Pfizer • pharmaceutical • smoking cessation • side effects • medication • Chantix

Congress
to Probe 'Misleading' Drug Ads

Cholesterol, anemia drugs in spotlight

May 8, 08 3:10 AM CDT
(Newser) - A congressional panel will examine three ad campaigns as part of a move to tighten regulations on drug companies' direct-to-consumer marketing, the Wall Street Journal reports. The committee will focus on ads for cholesterol drugs Vytorin and Lipitor, and anemia drug Procrit, which has been promoted as an anti-fatigue drug... More »

MORE ABOUT:
drugs • advertising • Merck • drug companies • Pfizer • Johnson and Johnson • congressional Democrats • Lipitor • Bart Stupak • Vytorin • Schering-Plough

1 - 20 of 33 Stories | 1 2 Next >>


from our news partners